Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,589 | 48,275 | 11,192 | 24,803 | 20,159 |
| Marketable Securities | N/A | N/A | 282 | 272 | 12,993 |
| Receivables | 3,224 | 2,085 | 4,971 | 2,870 | 52 |
| Other current assets | 1,025 | 950 | 599 | 767 | 736 |
| TOTAL | $37,838 | $51,310 | $17,044 | $28,712 | $33,940 |
| Non-Current Assets | |||||
| PPE Net | 2,070 | 2,466 | 5,189 | 6,825 | 4,330 |
| Intangibles | 3,980 | 3,759 | 3,268 | 3,067 | 2,559 |
| Other Non-Current Assets | 2,088 | 2,492 | 35 | 35 | 35 |
| TOTAL | $8,138 | $8,717 | $8,492 | $9,927 | $6,923 |
| Total Assets | $45,976 | $60,027 | $25,536 | $38,638 | $40,863 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 81 | 77 | 74 | 71 | N/A |
| Accounts payable and accrued liabilities | 1,311 | 1,381 | 2,014 | 3,026 | 1,402 |
| Accrued Expenses | 2,015 | 922 | 1,306 | 1,172 | 1,371 |
| Other current liabilities | 39,146 | 27,699 | 1,704 | 4,746 | 5,571 |
| TOTAL | $45,857 | $33,507 | $7,288 | $9,752 | $8,343 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,842 | 1,924 | 2,001 | 2,071 | N/A |
| Deferred Revenues | 3,304 | 3,428 | 2,190 | 738 | N/A |
| Other Non-Current Liabilities | 1,094 | 966 | 515 | 433 | 0 |
| TOTAL | $2,936 | $2,890 | $2,516 | $2,504 | $N/A |
| Total Liabilities | $48,793 | $36,397 | $9,804 | $12,256 | $8,343 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 18,764 | 18,403 | 14,277 | 10,799 | 8,882 |
| Common Shares | 11 | 11 | 7 | 6 | 5 |
| Retained earnings | -307,646 | -275,469 | -250,310 | -226,358 | -199,190 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 18 |
| TOTAL | $-2,817 | $23,630 | $15,732 | $26,382 | $32,519 |
| Total Liabilities And Equity | $45,976 | $60,027 | $25,536 | $38,638 | $40,863 |